![Mathew David](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathew David
Finanzdirektor/CFO bei
ACTINIUM PHARMACEUTICALS, INC.
Vermögen: 280 000 $ am 30.09.2026
Profil
Dr. Mathew T.
David, MD, is a Chief Financial Officer at Actinium Pharmaceuticals, Inc. Dr. David was previously employed as a Chief Business Officer & Executive Vice President by CorMedix, Inc. and a Head-Strategy by Ovid Therapeutics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from New York University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.10.2026 | 250 000 ( 0,8 % ) | 280 000 $ | 30.09.2026 |
Aktive Positionen von Mathew David
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 14.10.2026 |
Ehemalige bekannte Positionen von Mathew David
| Unternehmen | Position | Ende |
|---|---|---|
| OVID THERAPEUTICS INC. | Corporate Officer/Principal | - |
| CORMEDIX INC. | Vorstandsvorsitzender | 10.05.2022 |
Ausbildung von Mathew David
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
